Skip to main content
Premium Trial:

Request an Annual Quote

Illumina Sells BeadLab Station to Mayo Clinic

NEW YORK, Jan. 19 (GenomeWeb News) - Mayo Clinic will purchase a BeadLab genotyping system from Illumina to study cancer and other complex diseases, the company said today.


Mayo researchers plan to use the station initially mainly for genomic studies of cancer and various neuropsychiatric and cardiovascular disorders.


The system, which will be installed at Mayo's Rochester, Minn., location and be able to produce one million genotypes per day, will be available to investigators at all three Mayo Clinic sites. The other two sites are located in Jacksonville, Fla., and Scottsdale, Ariz.

The Scan

New Study Investigates Genomics of Fanconi Anemia Repair Pathway in Cancer

A Rockefeller University team reports in Nature that FA repair deficiency leads to structural variants that can contribute to genomic instability.

Study Reveals Potential Sex-Specific Role for Noncoding RNA in Depression

A long, noncoding RNA called FEDORA appears to be a sex-specific regulator of major depressive disorder, affecting more women, researchers report in Science Advances.

New mRNA Vaccines Offer Hope for Fighting Malaria

A George Washington University-led team has developed mRNA vaccines for malaria that appear to provide protection in mice, as they report in NPJ Vaccines.

Unique Germline Variants Found Among Black Prostate Cancer Patients

Through an exome sequencing study appearing in JCO Precision Oncology, researchers have found unique pathogenic or likely pathogenic variants within a cohort of Black prostate cancer patients.